ACM
QNRX

AIGH Capital Management’s Quoin Pharmaceuticals QNRX Stock Holding History

AIGH Capital Management’s Portfolio QNRX Stock Details QNRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$339K Buy
70,000
+19,000
+37% +$103K 0.02% 44
2026
Q1 		$337K Buy
51,000
+1,677
+3% +$15.2K 0.05% 42
2025
Q4 		$712K Buy
+49,323
New +$671K 0.17% 32

Other funds holding QNRX

DIG
Dauntless Investment Group Etna, New Hampshire $127M AUM 42.43% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $177M AUM 91.13% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
SC
SummitTX Capital Fort Worth, Texas $3.89B AUM 55.94% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.6B AUM 109.3% 1-Year Est. Return
VCIM
Velan Capital Investment Management Alpharetta, Georgia $164M AUM 542.31% 1-Year Est. Return

AIGH Capital Management's QNRX Position: Q2 2026 in Review

AIGH Capital Management increased its Quoin Pharmaceuticals (QNRX) stake by 37% in Q2 2026, buying an estimated $103K and bringing the position to 70,000 shares worth $339K. The position accounts for 0.02% of the portfolio, ranked #44.

AIGH Capital Management first reported a position in QNRX in Q4 2025 and has held it in 3 quarters since. The position peaked at $712K in Q4 2025. 20 funds tracked by Wall St. Rank hold QNRX as of Q2 2026.

  • AIGH Capital Management held 70,000 shares of Quoin Pharmaceuticals worth $339K as of Q2 2026.
  • AIGH Capital Management bought 19,000 Quoin Pharmaceuticals shares in Q2 2026, an estimated $103K.
  • Quoin Pharmaceuticals made up 0.02% of AIGH Capital Management's portfolio in Q2 2026, its #44 holding.
  • AIGH Capital Management first reported a position in Quoin Pharmaceuticals in Q4 2025 and has held it in 3 quarters since.
  • AIGH Capital Management's Quoin Pharmaceuticals position peaked at $712K in Q4 2025.
  • 20 funds tracked by Wall St. Rank held Quoin Pharmaceuticals as of Q2 2026.

Based on AIGH Capital Management's 13F filing for Q2 2026, filed 7 Aug 2026.